Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.

Fiche publication

Date publication

mai 2020

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FAGNONI Philippe , Dr FOUCHER Pascal , Pr QUANTIN Catherine

Tous les auteurs :
Howlett J, Benzenine E, Cottenet J, Foucher P, Fagnoni P, Quantin C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32448219

Résumé

Venous thromboembolism (VTE) is highly prevalent in cancer patients and can cause severe morbidity. VTE treatment is essential, but anticoagulation increases the risk of major bleeding. The purpose was to evaluate the impact of VTE and major bleeding on survival and to identify significant risk factors for these events in lung cancer patients.